On ECHEMI
Home > Drugs > China Resources Double-Crane Pharmaceutical Co., Ltd.
China Resources Double-Crane Pharmaceutical Co., Ltd.
  • Founded in:

    1997-05-16
  • Country:

    China China
  • Address:

    No. 1, Lize East 2nd Road, Wangjing, Chaoyang District, Beijing
  • Tax NO.:

    91110000633796475U
  • Registered Funds:

    1,038,836,522 yuan
  • Website:

  • Email:

Related Drugs
Children's paracetamol and yellow amine tablets
This product is a compound preparation, each tablet contains 125 mg of acetaminophen, 0.5 mg of chlorpheniramine maleate, and 5 mg of artificial bezoar.
Name Description Content CAS NO. Registered Holders
Acetaminophen

It can inhibit the synthesis of prostaglandins and has antipyretic and analgesic effects

More

It can inhibit the synthesis of prostaglandins and has antipyretic and analgesic effects

125mg 103-90-2 68
Chlorphenamine maleate

It is an antihistamine that can relieve runny nose, nasal congestion, and sneezing symptoms.

More

It is an antihistamine that can relieve runny nose, nasal congestion, and sneezing symptoms.

0.5mg 113-92-8 28
Atificial Cow-bezoar

It has antipyretic and sedative effects

More

It has antipyretic and sedative effects

5mg 1002-00-2 2
Valacyclovir Hydrochloride
Name Description Content CAS NO. Registered Holders
Valacyclovir Hcl

No specific description provided

More

No specific description provided

136489-37-7 138
Compound acetaminophen tablets
This product is a compound preparation. Each tablet contains the main ingredients of 126 mg of acetaminophen, 230 mg of aspirin, and 30 mg of caffeine.
Name Description Content CAS NO. Registered Holders
Acetaminophen

By inhibiting cyclooxygenase, it selectively inhibits the synthesis of prostaglandins in the hypothalamic temperature regulation center, leading to peripheral vasodilation and sweating to achieve an antipyretic effect; by inhibiting the synthesis and release of prostaglandins, it increases the pain threshold and has an analgesic effect. It is a peripheral analgesic, weaker than aspirin, and is only effective for mild and moderate pain. This product has no obvious anti-inflammatory effect.

More

By inhibiting cyclooxygenase, it selectively inhibits the synthesis of prostaglandins in the hypothalamic temperature regulation center, leading to peripheral vasodilation and sweating to achieve an antipyretic effect; by inhibiting the synthesis and release of prostaglandins, it increases the pain threshold and has an analgesic effect. It is a peripheral analgesic, weaker than aspirin, and is only effective for mild and moderate pain. This product has no obvious anti-inflammatory effect.

126mg 103-90-2 68
Acetylsalicylic acid

By inhibiting cyclooxygenase, it selectively inhibits the synthesis of prostaglandins in the hypothalamic temperature regulation center, leading to peripheral vasodilation and sweating to achieve an antipyretic effect; by inhibiting the synthesis and release of prostaglandins, it increases the pain threshold and has an analgesic effect. It is a peripheral analgesic, weaker than aspirin, and is only effective for mild and moderate pain. This product has no obvious anti-inflammatory effect.

More

By inhibiting cyclooxygenase, it selectively inhibits the synthesis of prostaglandins in the hypothalamic temperature regulation center, leading to peripheral vasodilation and sweating to achieve an antipyretic effect; by inhibiting the synthesis and release of prostaglandins, it increases the pain threshold and has an analgesic effect. It is a peripheral analgesic, weaker than aspirin, and is only effective for mild and moderate pain. This product has no obvious anti-inflammatory effect.

230mg 50-78-2 35
Caffeine

No specific pharmacological effects mentioned

More

No specific pharmacological effects mentioned

30mg 0
Calcium Gluconate Tablets
Each tablet contains 45mg calcium
Name Description Content CAS NO. Registered Holders
Calcium

Participates in the formation of bones and the reconstruction of bone tissue after fracture, muscle contraction, nerve transmission, coagulation process and reduces the permeability of capillaries, etc.

More

Participates in the formation of bones and the reconstruction of bone tissue after fracture, muscle contraction, nerve transmission, coagulation process and reduces the permeability of capillaries, etc.

45mg 7440-70-2 0
Hydroxyethyl starch (200/0.5) sodium chloride injection
This product is a compound preparation, its components are: hydroxyethyl starch (200/0.5) and sodium chloride. Each bottle (or bag) contains 30 grams of hydroxyethyl starch (200/0.5) and 4.5 grams of sodium chloride.
Name Description Content CAS NO. Registered Holders
Hydroxyethyl starch 200/0.5

Blood volume expander. The volume expansion effect and blood dilution effect of hydroxyethyl starch solution depend on the molecular weight, degree of substitution, substitution mode and drug concentration of hydroxyethyl starch, as well as the dosage and speed of administration. Rapid infusion of this product has a volume expansion effect of 100% of the infusion amount and lasts for 3 to 4 hours, after which the blood volume continues to decrease. At least within 3 to 4 hours, blood volume, hemodynamics and tissue oxygen supply will be improved. At the same time, due to the reduction of red blood cell aggregation, hematocrit and blood viscosity, blood rheology indicators are improved, thereby improving the circulation and microcirculation system.

More

Blood volume expander. The volume expansion effect and blood dilution effect of hydroxyethyl starch solution depend on the molecular weight, degree of substitution, substitution mode and drug concentration of hydroxyethyl starch, as well as the dosage and speed of administration. Rapid infusion of this product has a volume expansion effect of 100% of the infusion amount and lasts for 3 to 4 hours, after which the blood volume continues to decrease. At least within 3 to 4 hours, blood volume, hemodynamics and tissue oxygen supply will be improved. At the same time, due to the reduction of red blood cell aggregation, hematocrit and blood viscosity, blood rheology indicators are improved, thereby improving the circulation and microcirculation system.

30g 0
Sodium chloride

No specific pharmacological effects mentioned

More

No specific pharmacological effects mentioned

4.5g 7647-14-5 43
Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.